Nucleic Acid Labeling Market Report 2025

The nucleic acid labeling market size has grown strongly in recent years. It will grow from $2.56 billion in 2024 to $2.77 billion in 2025 at a compound annual growth rate (CAGR) of 8.2%. The growth in the historic period can be attributed to increased healthcare expenditure, rise in r&d spending, increased genomics research and disease diagnosis, increased demand for personalized medicine, healthcare infrastructure.

The nucleic acid labeling market size is expected to see strong growth in the next few years. It will grow to $4.01 billion in 2029 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to rising health awareness among people, growing penetration of key global players, increasing focus on patient-centered approaches, growing biotechnology sector, increasing use of dna sequencing. Major trends in the forecast period include advancements in tools for synthetic biology, advancements in labeling techniques, development of novel labeling techniques, innovative fluorescent dyes, integration of new labeling technologies in research and therapeutics.

The expected increase in infectious diseases is set to drive the growth of the nucleic acid labeling market in the future. Infectious diseases, caused by microscopic organisms such as parasites, fungi, viruses, and bacteria, spread through direct or indirect contact. Nucleic acid labeling techniques enhance the detection of infectious diseases such as tuberculosis, hepatitis, and gonorrhea, offering improved specificity, sensitivity, multiplexing capability, visualization, real-time monitoring, and automation. For example, in March 2023, the Centers for Disease Control and Prevention reported 8,300 cases of tuberculosis (TB) in the United States in 2022, reflecting a rise from 7,874 cases in 2021. The incidence of tuberculosis (TB) slightly increased to 2.5 incidents per 100,000 people in 2022. Thus, the surge in infectious diseases contributes to the growth of the nucleic acid labeling market.

The increasing funding for genomic research is expected to drive the growth of the nucleic acid labeling market. Such funds refer to financial resources dedicated to supporting scientific investigations and studies in genomics. This funding advances nucleic acid labeling by fostering the development of cutting-edge technologies, providing essential infrastructure, nurturing expertise, and facilitating collaboration. For instance, the National Human Genome Research Institute, a US-based government center, received $614 million in 2021 and $616 million in 2022. The proposed budget for 2023 allocates $629 million for the institute. Therefore, the rising funds for genomic research are propelling the growth of the nucleic acid labeling market.

A key trend gaining popularity in the nucleic acid labeling market is technological advancements. Major companies in the market are focusing on nanotechnology advancements to maintain their market positions. For instance, in January 2023, Cambridge Nucleomics, a UK-based biotechnology company, introduced a new technology called nano bait, which enables highly multiplexed detection of nucleic acid signatures caused by respiratory pathogens. This technology offers a faster solution for viral RNA detection compared to other techniques.

Major companies operating in the nucleic acid labeling market are making significant investments. Investments in nucleic acid labeling involve financial contributions to initiatives, companies, or projects related to nucleic acid labeling technologies, research, and development. In January 2023, Agilent Technologies Inc., a US-based provider of software and instruments for laboratories, invested $725 million to double its therapeutic nucleic acids production capacity. This strategic move aims to meet the growing demand for high-quality active pharmaceutical ingredients used in drugs targeting various diseases, including cancer, cardiovascular issues, and rare and infectious diseases.

In January 2023, ALS Limited, an Australia-based testing labs operator, acquired Invitek Molecular GmbH for an undisclosed sum. With this acquisition, ALS Limited aims to expand its expertise and provide in-vitro diagnostics firms worldwide with custom development and contract manufacturing services in the nucleic acid labeling market. Invitek Molecular GmbH is a Germany-based manufacturer of molecular diagnostic tools operating in the nucleic acid labeling market.

Major companies operating in the nucleic acid labeling market include General Electric Company, F. Hoffman-La Roche AG, Thermo Fisher Scientific Inc., Merck Group, Roche Diagnostics Corporation, GE Healthcare Bio Sciences AB, Agilent Technologies Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Cytiva, Qiagen N.V., Biotium Inc., Illumina Inc., LGC Group, Promega Corporation, New England Biolabs, Enzo Biochem Inc., LI-COR Biosciences Inc., Eurogentec S.A., OriGene Technologies Inc., BaseClear B.V., Vector Laboratories Inc., Bio-Synthesis Inc., BioCat GmbH, Jena Bioscience GmbH, LubioScience GmbH, GeneCopoeia Inc., Mirus Bio LLC, Daicel Arbor Biosciences.

North America was the largest region in the nucleic acid labeling market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nucleic acid labeling market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the nucleic acid labeling market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

Nucleic acid labeling is the process of incorporating detectable tags or markers into DNA or RNA molecules. These tags serve the purpose of visualizing and detecting specific nucleic acid sequences or monitoring their presence, location, or activity in various experimental or diagnostic contexts.

The primary product types in nucleic acid labeling encompass kits, reagents, and instruments. Reagents refer to substances or compounds utilized in diagnostic tests or laboratory experiments to identify, analyze, or measure specific components in biological samples. Various labeling types include radioisotope or radioactive labels, non-radioactive labels, and diverse methods such as enzyme-based and chemical-based approaches. These applications find use in various techniques such as DNA sequencing, polymerase chain reaction, fluorescence in situ hybridization (FISH), microarrays, blotting, in situ hybridization, and others. Additionally, these products cater to diverse end-users including hospitals, clinics, diagnostic centers, and more.

The nucleic acid labeling market research report is one of a series of new reports that provides nucleic acid labeling market statistics, including nucleic acid labeling industry global market size, regional shares, competitors with a nucleic acid labeling market share, detailed nucleic acid labeling market segments, market trends, and opportunities, and any further data you may need to thrive in the nucleic acid labeling industry. This nucleic acid labeling market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The nucleic acid labeling market consists of revenues earned by entities by providing services such as radiolabeling, biotinylation, fluorescence labeling, and enzyme labeling. The market value includes the value of related goods sold by the service provider or included within the service offering. The nucleic acid labeling market also includes sales of labeled nucleotides, labeling kits, labeling enzymes and detection reagents. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.